HLA-B and toxic epidermal necrolysis: In similar, HLA‐B*15:02 and HLA‐A*31:01 increase the risk of Stevens–Johnson syndrome or toxic epidermal necrolysis in patients treated with carbamazepine or oxcarbazepine.34, 35, 36